Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-09

FDA Approved: DEFLAZACORT — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original ANDA for deflazacort from Aurobindo Pharma Limited, enabling a generic version of deflazacort to be marketed in the United States. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEFLAZACORT (Deflazacort)

Snippet

ORIG AP for DEFLAZACORT (DEFLAZACORT)